Skip to main content

Exponent (EXPO): Buy, Sell, or Hold Post Q1 Earnings?

EXPO Cover Image

Over the past six months, Exponent’s shares (currently trading at $75.10) have posted a disappointing 19.3% loss while the S&P 500 was down 1.6%. This may have investors wondering how to approach the situation.

Is there a buying opportunity in Exponent, or does it present a risk to your portfolio? Get the full breakdown from our expert analysts, it’s free.

Why Is Exponent Not Exciting?

Even though the stock has become cheaper, we're cautious about Exponent. Here are three reasons why we avoid EXPO and a stock we'd rather own.

1. Lackluster Revenue Growth

We at StockStory place the most emphasis on long-term growth, but within business services, a stretched historical view may miss recent innovations or disruptive industry trends. Exponent’s annualized revenue growth of 4.5% over the last two years aligns with its five-year trend, suggesting its demand was consistently weak. Exponent Year-On-Year Revenue Growth

2. Fewer Distribution Channels Limit its Ceiling

With $518.7 million in revenue over the past 12 months, Exponent is a small player in the business services space, which sometimes brings disadvantages compared to larger competitors benefiting from economies of scale and numerous distribution channels. On the bright side, it can grow faster because it has more room to expand.

3. New Investments Fail to Bear Fruit as ROIC Declines

ROIC, or return on invested capital, is a metric showing how much operating profit a company generates relative to the money it has raised (debt and equity).

We like to invest in businesses with high returns, but the trend in a company’s ROIC is what often surprises the market and moves the stock price. Unfortunately, Exponent’s ROIC has decreased significantly over the last few years. We like what management has done in the past, but its declining returns are perhaps a symptom of fewer profitable growth opportunities.

Exponent Trailing 12-Month Return On Invested Capital

Final Judgment

Exponent isn’t a terrible business, but it doesn’t pass our quality test. After the recent drawdown, the stock trades at 35.9× forward P/E (or $75.10 per share). At this valuation, there’s a lot of good news priced in - we think there are better opportunities elsewhere. Let us point you toward one of our top software and edge computing picks.

High-Quality Stocks for All Market Conditions

Market indices reached historic highs following Donald Trump’s presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth.

While this has caused many investors to adopt a "fearful" wait-and-see approach, we’re leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.